Figures & data
Table 1. Study characteristics of included studies for a systematic review of new diagnoses of chronic conditions after SARS-CoV-2 infection.
Table 2. Risk of bias assessment according to JBI’s Cohort Studies tool.
Table 3. Summary of Findings for new diagnoses of chronic conditions after SARS-CoV-2 infection.
Table 4. Summary of time-varying effects and subgroup analyses by variant in a systematic review of new diagnoses of chronic conditions after SARS-CoV-2 infection.
Abel KM, Carr MJ, Ashcroft DM, et al. Association of SARS-CoV-2 infection with psychological distress, psychotropic prescribing, fatigue, and sleep problems among UK primary care patients. JAMA Network Open. 2021;4(11):e2134803. Ayoubkhani D, Khunti K, Nafilyan V, et al. Post-COVID syndrome in individuals admitted to hospital with COVID-19: retrospective cohort study. BMJ (Clinical Research ed). 2021;372:n693. Bohlken J, Weber K, Riedel Heller S, et al. Mild cognitive disorder in post-COVID-19 syndrome: a retrospective cohort study of 67,000 primary care post-COVID patients. Journal of Alzheimer's Disease Reports. 2022;6(1):297–305. Chevinsky JR, Tao G, Lavery AM, et al. Late conditions diagnosed 1-4 months following an initial coronavirus disease 2019 (COVID-19) encounter: a matched-cohort study using inpatient and outpatient administrative data-United States, 1 March-30 June 2020. Clin Infect Dis. 2021 Jul 15;73(Suppl 1):S5–S16. Cohen K, Ren S, Heath K, et al. Risk of persistent and new clinical sequelae among adults aged 65 years and older during the post-acute phase of SARS-CoV-2 infection: retrospective cohort study. BMJ (Clinical Research ed). 2022;376:e068414. Daugherty SE, Guo Y, Heath K, et al. Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study. BMJ (Clinical Research ed). 2021;373:n1098. Donnachie E, Hapfelmeier A, Linde K, et al. Incidence of post-COVID syndrome and associated symptoms in outpatient care in Bavaria, Germany: a retrospective cohort study using routinely collected claims data. BMJ Open. 2022;12(9):e064979. Jacob L, Koyanagi A, Smith L, et al. No significant association between COVID-19 diagnosis and the incidence of depression and anxiety disorder? A retrospective cohort study conducted in Germany. J Psychiatr Res. 2022;147:79–84. Kompaniyets L, Bull-Otterson L, Boehmer TK, et al. Post-COVID-19 symptoms and conditions Among children and adolescents - United States, march 1, 2020-January 31, 2022. MMWR Morb Mortal Wkly Rep. 2022;71(31):993–999. Park HY, Song I-A, Lee SH, et al. Prevalence of mental illness among COVID-19 survivors in South Korea: nationwide cohort. BJPsych Open. 2021;7(6):e183. Pietropaolo M, Hotez P, Giannoukakis N. Incidence of an insulin-requiring hyperglycemic syndrome in SARS CoV-2-infected young individuals: Is it type 1 diabetes? Diabetes. 2022;71(12):2656–2663. Qureshi AI, Baskett WI, Huang W, et al. New-Onset dementia among survivors of pneumonia associated with severe acute respiratory syndrome coronavirus 2 infection. Open Forum Infect Dis. 2022;9(4):ofac115. Rao S, Lee GM, Razzaghi H, et al. Clinical features and burden of postacute sequelae of SARS-CoV-2 infection in children and adolescents. JAMA Pediatr. 2022;176(10):1000–1009. Rezel-Potts E, Douiri A, Sun X, et al. Cardiometabolic outcomes up to 12 months after COVID-19 infection. A matched cohort study in the UK. PLoS Med 2022;19(7):e1004052. Roessler M, Tesch F, Batram M, et al. Post-COVID-19-associated morbidity in children, adolescents, and adults: a matched cohort study including more than 157,000 individuals with COVID-19 in Germany. PLoS Med. 2022;19(11):e1004122. Tartof SY, Malden DE, Liu IA, et al. Health care utilization in the 6 months following SARS-CoV-2 infection. JAMA Netw Open. 2022;5(8):e2225657. Taquet M, Sillett R, Zhu L, et al. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients. Lancet Psychiatry. 2022;9(10):815–827. Taquet M, Luciano S, Geddes JR, et al. Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA. Lancet Psychiatry. 2021;8(2):130–140. Wang L, Davis PB, Volkow ND, et al. Association of COVID-19 with New-onset Alzheimer's disease. Journal of Alzheimer's Disease: Jad. 2022;89(2):411–414. Wang W, Wang C-Y, Wang S-I, et al. Long-term cardiovascular outcomes in COVID-19 survivors among non-vaccinated population: A retrospective cohort study from the TriNetX US collaborative networks. EClinicalMedicine. 2022;53:101619. Westman G, Zelano J. Epilepsy diagnosis after COVID-19: A population-wide study. Seizure. 2022;101:11–14. Xie Y, Al-Aly Z. Risks and burdens of incident diabetes in long COVID: a cohort study. Lancet Diabetes Endocrinol. 2022;10(5):311–321. Xie Y, Xu E, Bowe B, et al. Long-term cardiovascular outcomes of COVID-19. Nat Med 2022;28(3):583–590. Xu E, Xie Y, Al-Aly Z. Long-term neurologic outcomes of COVID-19. Nat Med. 2022;28:2406–2415. Zarifkar P, Peinkhofer C, Benros ME, et al. Frequency of neurological diseases after COVID-19, influenza A/B and bacterial pneumonia. Front Neurol. 2022;13:904796.